Sqi Diagnostics Inc Ord

0.1289+0.0039+3.12%Vol 1.24K1Y Perf -30.51%
Nov 26th, 2021 12:55
BID0.0000 ASK0.0000
Open0.1368 Previous Close0.1250
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     36.01
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
4.98 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.01 Standard Deviation0.23
Beta1.11 

Today's Price Range

0.12890.1368

52W Range

0.11250.4420

5 Year PE Ratio Range

-2.0000-2.5000

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.19%
1 Month
-13.13%
3 Months
-10.27%
6 Months
-31.02%
1 Year
-30.51%
3 Years
52.44%
5 Years
-
10 Years
0.00%

TickerPriceChg.Chg.%
SQIDF0.12890.00393.12
AAPL156.81-5.1300-3.17
GOOG2 856.12-78.2300-2.67
MSFT329.68-8.2300-2.44
XOM61.25-2.2300-3.51
WFC48.43-2.8800-5.61
JNJ159.20-1.0400-0.65
FB333.12-7.9400-2.33
GE97.84-4.3900-4.29
JPM161.93-5.0300-3.01
Financial StrengthValueIndustryS&P 500US Markets
2.30
2.80
0.55
1.29
-19.60
Leverage Ratio 3.20
ProfitabilityValueIndustryS&P 500US Markets
81.10
-999.80
-925.30
-653.90
-
RevenueValueIndustryS&P 500US Markets
624.48K
0.00
-6.76
-5.83
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.24K
Shares Outstanding0
Shares Float389.46M
Trades Count2
Dollar Volume161
Avg. Volume70.02K
Avg. Weekly Volume22.55K
Avg. Monthly Volume26.17K
Avg. Quarterly Volume28.76K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Sqi Diagnostics Inc Ord

SQI Diagnostics Inc is a Canada based diagnostics company. It is engaged in developing and commercializing proprietary technologies and products for multiplexing diagnostics. The company develops multiplexed tests and automated systems for customers to measure biomarkers in blood or other common sample types. It offers solutions to the testing needs of three markets namely, Pharmaceutical and Biotechnology drug development, Human diagnostic testing, and Animal health diagnostic testing. Its multiplexed products and services include detecting and quantifying proteins, antibodies, and DNA. The company principally operates in the geographic regions of North America and Europe, of which majority of the revenue is derived from Europe.

CEO: Andrew Morris

Telephone: +1 416 674-9500

Address: 36 Meteor Drive, Toronto M9W 1A4, ON, CAN

Number of employees: 42

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

38%62%

News